logo
Avian Flu Wiped Out Poultry. Now the Screwworm Is Coming for Beef.

Avian Flu Wiped Out Poultry. Now the Screwworm Is Coming for Beef.

New York Times28-07-2025
First came bird flu, which led to the culling of large swaths of the nation's poultry flocks and the soaring egg prices that helped undermine President Joseph R. Biden Jr.'s re-election. Now, ranchers in Texas and officials at the Agriculture Department are raising the next alarm: the New World screwworm.
Texas livestock producers and ranchers fear the United States is ill-equipped to handle a potential outbreak of screwworm, whose incursion into the country appears increasingly likely. With beef prices already soaring, the screwworm, whose Latin name roughly translates to 'man-eater,' is a real threat, to both cows and the cost of living for America's meat lovers.
'If we wait, we lose,' Stephen Diebel, vice president of the Texas and Southwestern Cattle Raisers Association, told state lawmakers during a hearing in Austin this week as he pleaded for intervention.
The screwworm, like the measles, may have been forgotten by many, but it's not new. And like the measles, which has cropped up in Texas recently, screwworm was once all but eradicated from the United States.
Infestations occur when a female fly lays eggs, between 10 and 400 at a time, on a fresh animal wound. Within a few hours, the eggs hatch into larvae that burrow and feed on the flesh. As the wound worsens, it attracts more flies, which lay more eggs. After about a week, adult screwworm flies can reproduce and begin the cycle all over again. The parasitic infection can kill a cow within two weeks if left untreated. There is currently no approved treatment.
'It's like something out of a horror movie,' the Texas agriculture commissioner, Sid Miller, said in an interview. He saw distressed cattle infested with screwworm when he was a child in the early 1960s before it was nearly eradicated. 'It's quite a putrid sight,' he said.
Want all of The Times? Subscribe.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Merging deep tech and biomedical science expertise, ChronicleBio aims to accelerate breakthroughs for millions living with complex chronic conditions
Merging deep tech and biomedical science expertise, ChronicleBio aims to accelerate breakthroughs for millions living with complex chronic conditions

Yahoo

time18 minutes ago

  • Yahoo

Merging deep tech and biomedical science expertise, ChronicleBio aims to accelerate breakthroughs for millions living with complex chronic conditions

New venture harnesses multi-omic data and AI to develop the largest platform on complex chronic illnesses to drive breakthroughs in POTS, ME/CFS, Long COVID, and other neuroimmune disorders SAN FRANCISCO, Aug. 5, 2025 /PRNewswire/ -- ChronicleBio, a techbio startup focused on radically accelerating insights on neuroimmune disorders, officially launched Tuesday with a bold mission: to build the world's richest, AI-ready data platform for historically overlooked conditions like POTS, ME/CFS, Long COVID, and other complex chronic conditions. ChronicleBio is uniquely led by a founding team that unites elite tech, healthcare, and life sciences: Fidji Simo (Co-founder), current CEO of Instacart and the incoming CEO of OpenAI's applications division, brings deep expertise in consumer-scale technology, product innovation, and health systems transformation. Rohit Gupta (Co-founder & CEO), a biobanking and precision medicine leader who previously oversaw centers at Stanford and UCSF, is the leading scientific and strategic force behind ChronicleBio. Rishi Reddy (Co-founder & Executive Chairman), of Tarsadia Investments, brings an entrepreneurial and venture-backed perspective and a track record in health and life sciences investing. Together, they are tackling a critical gap in biomedical research. ChronicleBio is creating a scalable, ethically driven data ecosystem, integrating clinical, molecular, biospecimen, and patient-reported insights to drive biomarker discovery, patient stratification, and precision therapeutic development. "Entire communities of patients have been ignored for too long, not because their conditions aren't debilitating and prevalent, but because the systems weren't built to understand them," said Fidji Simo, co-founder of ChronicleBio. "ChronicleBio is developing a future where patients can enlist in research, and where the data we collect from them goes directly towards better diagnostics and therapeutics. By building these critical missing datasets and leveraging the massive advances in AI, we aim to accelerate the path to cures." These complex chronic conditions impact nearly 300 million people worldwide, but remain woefully understudied, leaving patients hopeless and without meaningful treatments. It's a disease space desperate for data, and ChronicleBio is offering the scalable solutions to provide it. "Neuroimmune disorders remain some of the most poorly understood in medicine and not for lack of interest, but because the underlying data simply doesn't exist at the scale or structure required for serious breakthroughs," said Rohit Gupta, co-founder and CEO of ChronicleBio. "We're empowering patients and clinicians to get involved in this effort to grow our research-grade biobank and AI-ready data platform so we can close that gap and provide the tools to finally interrogate these diseases with scientific rigor and precision, bringing an end to complex chronic conditions." ChronicleBio partners directly with patients, clinics, and research collaborators to generate longitudinal, multi-modal datasets, including genomics, immune profiling, and real-world outcomes designed for exploration and clinical trial readiness. Its platform is already being used in multiple high-integrity clinics in the U.S. and India, as well as through research collaborations with thousands of patients contributing data and biosamples. "We're creating an ecosystem with global reach, designed not just to generate data, but to fundamentally shift how we discover, develop, and deliver treatments at scale. The opportunity for impact—scientifically, medically, and societally—is enormous," said Rishi Reddy, co-founder and Executive Chairman of ChronicleBio. "We're building the foundational infrastructure for a massive medical need that has been hiding in plain sight." ChronicleBio's founding vision isn't just ambitious. It's personal. Both Simo and Reddy have been diagnosed with at least one of the very conditions the company is focused on researching. Gupta's family also suffers from neuroimmune disorders. The group's world-class expertise is outshined only by its heartfelt determination to rewrite the scientific narrative for the millions of patients overlooked by traditional research and transform lived experience into actionable discovery. ChronicleBio's approach includes: A global biobank platform collecting and connecting data on neuroimmune illnesses A proprietary, AI-ready data engine designed to integrate multi-omic, clinical, and real-world evidence Strategic partnerships with clinics, research consortia, and biotech sponsors looking to unlock hard-to-crack therapeutic areas A decentralized clinical trial network accelerating drug development through real-world access to patients and clinicians For more information, visit or follow ChronicleBio on LinkedIn, X, Instagram, and Facebook. Media Contact:media@ View original content to download multimedia: SOURCE ChronicleBio Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

What to know about Legionnaires' disease, which has sickened dozens in New York City
What to know about Legionnaires' disease, which has sickened dozens in New York City

Yahoo

time18 minutes ago

  • Yahoo

What to know about Legionnaires' disease, which has sickened dozens in New York City

An outbreak of Legionnaires' disease in New York City has killed two people and sickened 58 since late July. City health officials link the Central Harlem outbreak to cooling towers, structures containing water and a fan that are used to cool buildings. They said 11 of these towers initially tested positive for a type of bacteria that causes Legionnaires' disease, but the problem has been remedied. They urged people in the area with flu-like symptoms to contact a health care provider as soon as possible, especially if they are 50 or older, smoke or have chronic lung conditions. Here's what to know. What is Legionnaires' disease? It's a type of pneumonia caused by Legionella bacteria, which grow in warm water and spread in building water systems. They can be found in places such as showerheads, hot tubs and cooling towers. People often get the disease by inhaling aerosols from contaminated water. Hospital patients can also contract it through contaminated water or ice, and babies can be exposed during water births, health officials said. People don't get it from each other. Symptoms usually develop two days to two weeks after exposure and include cough, fever, headaches, muscle aches and shortness of breath, according to the U.S. Centers for Disease Control and Prevention. How does Legionnaires' disease hurt you and how can you treat it? It's important to be diagnosed quickly and treated with the appropriate antibiotics, health officials said. If untreated, the disease usually worsens during the first week, the World Health Organization said. Complications can include respiratory failure, shock and kidney or multi-organ failure. How can Legionnaires' disease be prevented? People responsible for the safety of buildings and water systems can reduce the threat by taking steps to minimize the growth of the bacteria, the WHO said. For example, they should regularly clean and disinfect cooling towers, maintain an adequate level of chlorine in spa pools and flush unused taps in buildings weekly. There are also steps people can take to reduce the risk of Legionnaires' disease at home. New York state health officials suggest draining garden hoses; following manufacturers' instructions for cleaning and replacing water filters; checking chlorine levels in pools and hot tubs regularly and flushing hot water heaters twice a year. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Solve the daily Crossword

Illinois Bans AI From Providing Therapy
Illinois Bans AI From Providing Therapy

Gizmodo

time19 minutes ago

  • Gizmodo

Illinois Bans AI From Providing Therapy

Illinois Governor JB Pritzker signed, on Friday, a new measure that bans AI from acting as a therapist or counselor and limits its use to strictly administrative or support roles. The Wellness and Oversight for Psychological Resources Act comes as states and federal regulators are starting to grapple with how to protect patients from the growing and mostly unregulated use of AI in health care. The new law prohibits individuals and businesses from advertising or offering any therapy services, including via AI, unless those services are conducted by a licensed professional. It explicitly bans AI from making independent therapeutic decisions, generating treatment plans without the review and approval from a licensed provider, and detecting emotions or mental states. That said, AI platforms can still be used for administrative tasks, such as managing appointment schedules, processing billing, or taking therapy notes. People or companies that violate the law could face fines of up to $10,000. 'The people of Illinois deserve quality healthcare from real, qualified professionals and not computer programs that pull information from all corners of the internet to generate responses that harm patients,' said Mario Treto, Jr, secretary of the Illinois Department of Financial and Professional Regulation, the agency that is charged with enforcing this new law, in a press release. Meanwhile, other states are also taking action on the issue. In June, Nevada banned AI from providing therapy or behavioral health services that would normally be performed by licensed professionals, particularly in public schools. Utah passed several of its own AI regulations earlier this year, including one focusing on mental health chatbots. That law requires companies to clearly disclose that users are interacting with an AI and not a human before a user first uses the chatbot, after seven days of inactivity, and whenever the user asks. The chatbots must also clearly disclose any ads, sponsorships, or paid relationships. Additionally, they're banned from using user input for targeted ads and are restricted from selling users' individually identifiable health information. And in New York, a new law going into effect on November 5, 2025, will require AI companions to direct users who express suicidal thoughts to a mental health crisis hotline. These new state laws come after the American Psychological Association (APA) met with federal regulators earlier this year to raise concerns that AI posing as therapists could put the public at risk. In a blog post, the APA cited two lawsuits filed by parents whose children used chatbots that allegedly claimed to be licensed therapists. In one case, a boy died by suicide after extensive use of the app. In the other, a child attacked his parents.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store